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The Polycomb group transcriptional repressor Bmi-1
is often upregulated in prostate cancer, but its func-
tional roles in prostate stem cell maintenance and
prostate cancer are unclear. Loss- and gain-of-func-
tion analysis in a prostate sphere assay indicates
that Bmi-1 expression is required for self-renewal
activity and maintenance of p63+ stem cells. Loss of
Bmi-1 blocks the self-renewal activity induced by
heightened b-catenin signaling, suggesting that
Bmi-1 is required for full activity of another self-
renewal pathway. In vivo, Bmi-1 expression is neces-
sary for normal prostate tubule regeneration. Altered
self-renewal and proliferation throughBmi-1modula-
tion diminishes the susceptibility of prostate cells to
transformation. In an in vivo prostate regeneration
system, Bmi-1 inhibition protects prostate cells from
FGF10-driven hyperplasia and slows the growth of
aggressive Pten-deletion-induced prostate cancer.
We conclude that Bmi-1 is a crucial regulator of self-
renewal in adult prostate cells and plays important
roles in prostate cancer initiation and progression.
INTRODUCTION
Adult stem cells require self-renewal to maintain organ homeo-
stasis and replenish the stem cell pool after tissue injury (He
et al., 2009). Self-renewal mechanisms that allow stem cells to
persist usually involve proto-oncogenic pathways such as Wnt,
Shh, Notch, and the polycomb group genes (Gil et al., 2005;
Reya et al., 2001). Components of these tissue-specific self-
renewal pathways are found mutated or upregulated in many
malignancies and have been shown to contribute to cancer
progression (Pardal et al., 2005).
The Polycomb-group transcriptional repressor Bmi-1 has
emerged as a key regulator in several cellular processes
including stem cell self-renewal and cancer cell proliferation.682 Cell Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier IncBmi-1 was first identified in 1991 as a frequent target of Moloney
virus insertion in virally accelerated B-lymphoid tumors of E
mu-myc transgenic mice (van Lohuizen et al., 1991). The main
target of Bmi-1 repression is the Cdkn2a locus, which encodes
two structurally distinct proteins, p16Ink4a and p19ARF, both of
which restrict cellular proliferation in response to aberrant mito-
genic signaling (Jacobs et al., 1999). Bmi-1 has been implicated
in the modulation of self-renewal in several types of stem cells,
including hematopoietic (Park et al., 2003), neural (Molofsky
et al., 2005), and mammary (Liu et al., 2006). Bmi-1 gene ampli-
fication and protein overexpression are also commonly found in
cancers of these tissues. In the hematopoietic system, Bmi-1 is
required for the proliferation and tumor-initiating capacities of
leukemic stem cells (Lessard and Sauvageau, 2003). In the
nervous system, Bmi-1 is a marker of poor prognosis in oligo-
dendroglial tumors (Ha¨yry et al., 2008) and is essential for the
tumorigenicity of neuroblastoma cells (Cui et al., 2007). These
observations suggest that inherent self-renewal pathways like
Bmi-1 are important for the maintenance of both normal stem
cells and cancer cells of a given tissue.
Prostate cancer is the most frequently diagnosed nonskin
cancer and second most common cause of cancer-related
deaths in men (Carson, 2006). Patients not suitable for radio-
therapy or surgery are treated with androgen ablation therapy,
which effectively shrinks androgen-dependent tumors (Huggins
and Hodges, 1941). Unfortunately, this treatment is often fol-
lowed by recurrent androgen-independent prostate cancer,
with frequent metastases (Shaw et al., 2007). The existence of
prostate stem cells was elucidated when Isaacs and colleagues
found that a fraction of prostate cells remain after castration-
induced involution and are capable of regenerating the full gland
with all of its different cell lineages (Isaacs, 1987). Certain
prostate cancer cells share properties with normal adult prostate
stem cells and have the ability to survive androgen ablation
therapy and subsequently regenerate the tumor with a more
aggressive phenotype (Litvinov et al., 2003).
Bmi-1 is overexpressed in prostate cancer with adverse
pathologic and clinical features. Tumors with Gleason scores
of 8 or higher have a significant upregulation of Bmi-1, whereas
the presence of Bmi-1 in lower grade prostate cancer samples is
highly predictive for prostate-specific antigen (PSA) recurrence.
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Figure 1. Bmi-1 Is Expressed in the Stem
Cell-Enriched Regions and Cell Fractions
of Adult Prostate
(A) FACS plots of the luminal (CD49floSca-1, blue)
and ‘‘LSC’’ basal/stem (CD49f+Sca-1+, red) cell
populations. Graph shows Bmi-1 mRNA levels in
the luminal and LSC cells of adult mouse prostate.
(B) Quantification of the Bmi-1+ cells in the prox-
imal and distal regions of adult prostate. Repre-
sentative images show Bmi-1 staining in these
regions. Scale bars represent 100 mm.
(C) Image shows representative area from the
proximal region costained with Bmi-1 and cytoker-
atin (CK) 5. Scale bar represents 50 mm.
(D) Bmi-1 mRNA levels in intact and castrated
8-week-old prostates. Data shown asmean ± SEM.
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Bmi-1 in Prostate Stem Cells and Cancer(van Leenders et al., 2007). Microarray meta-analyses have
found that the presence of Bmi-1 in prostate cancer specimens
often indicates metastatic disease and a high probability of
unfavorable therapeutic outcome (Glinsky et al., 2005). Bmi-1
has been shown enriched in a population of prostate cancer cells
with higher tumor-initiating capacities (Hurt et al., 2008). These
observations allude to the functional involvement of Bmi-1 in
prostate cancer progression and maintenance. The ability of
Bmi-1 to control stem cell maintenance in other tissues raises
the question of whether Bmi-1 is an important regulator of self-
renewal in the prostate and whether this gene is involved in
prostate cancer development.
In the present studies, an in vitro sphere forming assay and
mouse tissue regeneration systems were used to elucidate the
role of Bmi-1 in regulating normal mouse prostate stem cell
(PrSC) self-renewal and cancer initiation. Lentiviral-delivered
shRNAs and overexpression clones were used to show that
modulation of Bmi-1 expression levels control prostate stem
cell self-renewal activity in vitro and prostatic tubule regenera-
tion in vivo. p63 is a marker for the more stem-like basal cells
of the prostate, which have higher self-renewal capacities. One
novel way that Bmi-1 was found to control self-renewal was
through the expansion and depletion of these p63+ cells in
spheres, which in turn affected their ability to passage. Trans-
genic mice were used to show that heightened b-catenin
signaling can also increase self-renewal activity in PrSCs.
Bmi-1 loss reverses this added self-renewal activity, further
highlighting the requirement of Bmi-1 in normal PrSC self-
renewal. In vivo, loss of Bmi-1 prevents hyperplastic growth
induced by paracrine growth factor signaling in primary prostateCell Stem Cell 7, 682–693,cells and attenuates the growth of
prostate cancer induced by a potent
cell-autonomous oncogene.
RESULTS
Bmi-1 Is Expressed in the Stem
Cell-Enriched Population
of Adult Prostate
Adult prostate stem cells (PrSCs) are
thought to be in the basal compartment
because basal cells preferentially surviveandrogen ablation (English et al., 1987) and can give rise to
luminal cells (Robinson et al., 1998). PrSCs are concentrated in
the region proximal to the urethra, because BrdU pulse-chase
experiments have shown label-retaining cells in that region
(Tsujimura et al., 2002). FACS sorting techniques have been
used to confirm that cells with stem-like capabilities like self-
renewal, multilineage differentiation, and tissue regeneration
are highly enriched in the proximal region (Goto et al., 2006;
Lawson et al., 2007). By using CD49f and Sca-1 surfacemarkers,
we can highly enrich the luminal (CD49floSca-1) and stem/basal
(CD49fhiSca-1+) cells from adult prostate (Lawson et al., 2010).
Q-PCR analysis of these populations reveals a 7-fold higher
Bmi-1 mRNA level in the basal/stem cell population than in the
more differentiated luminal cells (Figure 1A). Immunohistochem-
ical analyses of adult prostate sections show that Bmi-1+ cells
are enriched in the proximal region of the prostate (Figure 1B).
The majority of these cells coexpress the basal marker cytoker-
atin 5 (Figure 1C). Bmi-1 mRNA levels are also significantly
higher in prostates from castrated mice, which naturally contain
a higher percentage of stem cells (Figure 1D). Higher Bmi-1
expression in the region and cell population enriched for PrSCs
indicates that Bmi-1 may play a role in their maintenance.
Bmi-1 Regulates Self-Renewal Activity
in Adult Prostate Stem Cells
Stem cells from the mammary gland and brain have been
successfully maintained and passaged in vitro as floating spher-
oids (Dontu et al., 2003; Reynolds and Weiss, 1996). Sphere
numbers over multiple passages represent self-renewal activity,
whereas sphere size demonstrates progenitor cell proliferationDecember 3, 2010 ª2010 Elsevier Inc. 683
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Figure 2. Bmi-1 Expression Controls Sphere Formation and Self-Renewal in Adult Prostate Stem Cells
(A) Diagram of shRNA and Bmi-1Res lentivector constructs.
(B) Western blot of scrambled (Scr) shRNA-, Bmi-1 shRNA-, and Bmi-1 shRNA/Bmi-1Res-infected prostate cell lysates.
(C) Frequency of primary prostate spheres formed from infected cells. Sphere counts are normalized to mock infected spheres.
(D) Representative sphere images from each condition; transilluminating (TI) and fluorescence images show viral infection with respective shRNA (red) and
Bmi-1Res (green) virus. Scale bars represent 100 mm.
(E) Schematic of sphere passaging.
(F) Scrambled and Bmi-1 shRNA-infected prostate spheres were dissociated and equal numbers of cells were passaged for four generations. Spheres counts are
normalized to the first generation scrambled shRNA spheres. See also Figures S1A, S1B, and S2.
(G) Frequency of spheres from GFP- and Bmi-1-GFP-infected p53/ prostate cells. Spheres were dissociated and passaged at equal cell numbers for four
generations. Sphere counts are normalized to generation 1 GFP-infected spheres. Data represented as mean ± SEM. See also Figures S1C and S1D.
Cell Stem Cell
Bmi-1 in Prostate Stem Cells and Cancer(Dontu et al., 2004). PrSCs can be maintained in a semisolid
sphere assay, where they give rise to clonally derived spheres
and can be passaged for 12 generations, demonstrating self-
renewal activity (Xin et al., 2007). An shRNA-assisted knock-
down strategy was used to study the functional effect of Bmi-1
loss on adult prostate sphere formation and self-renewal.
We constructed lentiviral vectors that contain a potent shRNA
targeting Bmi-1 or a scrambled (Scr) shRNA under the control of
the H1 promoter and coexpressing RFP. To rule out off-target
effects of shRNA, a rescue Bmi-1 clone (Bmi-1Res) was created
by introduction of three silent point mutations into the shRNA684 Cell Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Inctarget region of murine Bmi-1 (Figure 2A). Knockdown and
rescue efficiencies were tested in primary prostate cells and
measured by western blot (Figure 2B). Dissociated primary pros-
tate cells were infected with lentivirus containing scrambled or
Bmi-1 shRNA, or coinfected with Bmi-1 shRNA and Bmi-1Res,
and plated in the prostate sphere assay. After 8 days in culture,
there was no difference in the numbers of spheres formed from
the mock and scrambled shRNA-infected cells. In contrast, the
Bmi-1 shRNA-infected cells had a 4-fold decrease in sphere
forming activity (Figure 2C). Introduction of Bmi-1Res completely
rescued the sphere forming activity of the prostate cells, ruling.
Cell Stem Cell
Bmi-1 in Prostate Stem Cells and Cancerout off-target effects. Bmi-1 knockdown spheres were on
average 6-fold smaller in diameter than the control spheres,
and introduction of Bmi-1Res rescued this phenotype as well
(Figures 2D). Bmi-1 is known to epigenetically repress p16 and
p19, which could affect proliferation. To elucidate whether these
pathways contribute to the decrease in sphere numbers and
sizes, scrambled and Bmi-1 shRNA-infected spheres were
analyzed by Q-PCR and western. Spheres with lower levels of
Bmi-1 showed a 35-fold increase in the mRNA levels of p16
and p19, which was confirmed at the protein level (Figures S1A
and S1B available online). Lentivirus-mediated coinfection of
prostate cells with p16 and p19 had a similar inhibitory effect
on sphere formation as Bmi-1 shRNA (Figure S2).
Scrambled and Bmi-1 shRNA-infected spheres were dissoci-
ated and passaged for several generations to test the effect of
Bmi-1 inhibition on self-renewal (Figure 2E). Whereas scrambled
shRNA-infected cells maintain a steady level of sphere-forming
activity, cells lacking Bmi-1 had a progressive decrease in self-
renewal and the capacity to form daughter spheres (Figure 2F).
Because only stem-like cells can give rise to new prostate
spheres, the diminished sphere formation represents a lower
frequency of stem-like cells in the absence of Bmi-1.
A lentiviral delivery system was also used to introduce exoge-
nous Bmi-1 in primary prostate cells to test whether heightened
expression would confer added self-renewal. Because Bmi-1
is a known oncogene, we used prostate cells from p53/
mice in the overexpression studies to minimize oncogenic
stress-induced apoptosis. We observed no difference in the
numbers of primary spheres that formed, indicating that addi-
tional Bmi-1 does not confer sphere forming activity to the
more differentiated prostate cells. Spheres from both conditions
were dissociated and passaged for four generations, and there
was a progressive increase in the sphere forming activity of the
Bmi-1-infected cells (Figure 2G). Cells with heightened Bmi-1
expression also formed larger spheres than the control infected
spheres. Q-PCR and western analyses of spheres infected with
GFP or Bmi-1 revealed a significant decrease in p16 and p19
mRNA and protein levels (Figures S1C and S1D). Therefore,
the increase in self-renewal and proliferation in response to
heightened Bmi-1 expression is at least partially achieved by
a loss of p16- and p19-driven senescence and apoptosis.
Bmi-1 Regulates the Maintenance of Self-Renewing
Cells in the Prostate
The LSC and LSCThi cell populations mark the stem cell fraction
in normal prostate (Goldstein et al., 2008; Lawson et al., 2007).
Once prostate cells are cultured, Sca-1 gets turned on, the
antigenic profile of the sphere cells shift, and quantification of
PrSCs becomes less reliable. The LSC and LSCThi fractions
were analyzed in Bmi-1 overexpression and knockdown spheres
and showed trends toward increased and decreased stem cell
populations, respectively (Figure S3). An alternative marker for
the more primitive prostate cells was also analyzed. p63 has
been shown to be crucial for normal prostate development
(Signoretti et al., 2000). p63 is almost exclusively expressed in
the LSC population (Lawson et al., 2010). p63+ cells have signif-
icantly higher self-renewal activity than p63 cells (Xin et al.,
2007), further indicating that p63 marks the more stem-like cells
of the prostate. Sphere sections from Bmi-1 knockdown andCeloverexpression experiments were stained for p63, counter-
stained with DAPI, and the average percentages of p63+ cells
were calculated to account for the differences in sphere sizes.
There is a 7-fold loss of p63+ cells in the Bmi-1 shRNA-infected
prostate spheres (Figures 3A and 3B). In contrast, sections of
p53/ spheres infected with exogenous Bmi-1 show a 2-fold
increase in the number of p63+ cells over GFP-infected p53/
spheres (Figures 3C and 3D). Prostate cells infected with scram-
bled or Bmi-1 shRNA and GFP or Bmi-1 lentivirus were analyzed
5 days after infection to test whether p63 was directly regulated
by Bmi-1. p63 expression did not change significantly in any of
the conditions at the mRNA or protein level (Figure S4). We
conclude that the changes in p63 expression patterns are due
to altered self-renewal in the p63+ population, rather than
Bmi-1 modulating the transcription or translation of p63.
Individual RFP+ spheres from the scrambled shRNA and
Bmi-1 shRNA-infected wells were picked, combined with
noncolored WT spheres, digested, and passaged to functionally
assess changes in stem cell populations. Although almost all
scrambled shRNA-infected spheres produces an average of 25
daughter spheres, only 30% of Bmi-1 shRNA-infected spheres
were able to passage at all, producing only 1–2 smaller
secondary spheres (Figures 3E and 3F; Table S1). Conversely,
exogenous Bmi-1-infected prostate spheres formed approxi-
mately 35%more daughter spheres than GFP-infected spheres,
which were also larger in size (Figures 3G and 3H; Table S1). The
shift in the p63+ stem-like population and the resulting changes
in individual sphere forming capacity corroborate that Bmi-1
expression levels modulate self-renewal activity.
Bmi-1 Is Necessary for b-Catenin-Induced Self-Renewal
Many of the self-renewal pathways are interconnected in vivo.
Studies suggest that Hedgehog (Hh) signaling is important for
normal prostate and mammary regeneration and tumor progres-
sion (Fiaschi et al., 2009; Karhadkar et al., 2004). Bmi-1 acts
downstream of Hh, and it is the level of Bmi-1 that ultimately
controls self-renewal (Liu et al., 2006). This demonstrates the
necessity of Bmi-1 expression for Hh-induced self-renewal.
Wnt signaling has also been shown to be active in PrSCs (Onti-
veros et al., 2008), and modulation of b-catenin activity leads
to altered sphere forming capacity of prostate cancer cells
(Bisson and Prowse, 2009). We investigated the effects of
Bmi-1 loss in the presence of overactivated Wnt signaling to
elucidate whether Bmi-1 expression is required for other path-
ways to modulate self-renewal in the prostate.
b-catenin is the key downstream signaling component of the
Wnt pathway. Stabilizing mutations in exon 3 of b-catenin
(Catnb) overactivate the pathway and have been reported in
many cancers (Morin et al., 1997). The conditional exon 3
knockout mouse (Catnb+/lox(ex3)) mimics such mutations, and
Wnt signaling is overactivated by introduction of Cre recombi-
nase (Harada et al., 1999). Overactivation of b-catenin during
prostate development increases the LSC population 2.5-fold
in the prostate (data not shown). Dissociated Catnb+/lox(ex3) pros-
tate cells were infected with RFP or Cre lentivirus to overactivate
b-catenin signaling, then plated in the sphere assay and
passaged (Figure 4A) to determine whether heightened b-cate-
nin signaling affects sphere formation and self-renewal in the
prostate. Cre-infected Catnb+/lox(ex3) cells had significantlyl Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Inc. 685
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Figure 3. Bmi-1 Regulates the Depletion and Expansion of Self-Renewing Cells in Prostate Spheres
(A) p63 and DAPI stains of scrambled (left) and Bmi-1 shRNA (right)-infected spheres.
(B) Percentage of p63+ cells in 12 representative scrambled and Bmi-1 shRNA-infected spheres.
(C) p63 and DAPI stains of GFP (left column) and Bmi-1 (right column)-infected p53/ prostate spheres.
(D) Percentage of p63+ cells in 12 representative GFP and Bmi-1-infected spheres.
(E and G) Number of daughter spheres formed from single dissociated scrambled and Bmi-1 shRNA-infected (E) and GFP and Bmi-1-infected (G) spheres.
(F and H) Merged images of representative daughter spheres formed from Bmi-1 shRNA-infected (F, red) and Bmi-1-GFP-infected (H, green) spheres.
Data represented as mean ± SEM. Scale bars represent 200 mm. See also Figures S3, S4, and Table S1.
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Bmi-1 in Prostate Stem Cells and Cancerhigher sphere forming capacity in generation 1 and increased
self-renewal in generation 2 (Figure 4B). Western blot analysis
shows that Cre-infected spheres have the exon 3 excised form
of b-catenin (Figure 4C, bottom band) in addition to the WT
protein (Figure 4C, top band). The mRNA and protein levels of
target genes c-Myc and Cyclin D1 increased in the Cre-infected
spheres, confirming increased b-catenin signaling (Figures 4C
and 4D). Bmi-1 mRNA levels were not significantly increased
and its predominant target genes p16 and p19were not affected,
indicating little to no change in Bmi-1 signaling with stabilized
b-catenin.
Catnb+/lox(ex3) primary prostate cells were infected with
Cre/scrambled or Cre/Bmi-1 shRNA lentivirus, to investigate
the effects of Bmi-1 loss in the presence of heightened b-catenin
signaling. Cre/scrambled shRNA infection increased sphere
forming activity and sphere size (Figure 4E). In contrast,
Cre/Bmi-1 shRNA-infected cells formed significantly fewer and
smaller spheres than even the noninfected Catnb+/lox(ex3) cells
(Figure 4E). p16 and p19 levels increased upon Bmi-1 inhibition,
which must have contributed to this result (Figure S1E). The
difference in sphere forming activity was even more striking
upon passaging, indicating that loss of Bmi-1 not only reverses
the gain of self-renewal activity induced by heightened Wnt
signaling, but represses it even further. Introduction of Bmi-1Res
rescued both sphere forming activity and sphere size (Figure S5).
These results highlight the importance of Bmi-1 in stem cell686 Cell Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Incmaintenance and suggest that Bmi-1 presence is required for
full functional activity of at least one independent self-renewal
pathway.
Bmi-1 Inhibition Decreases Tubule Forming Activity
In Vivo
Another unique property of stem cells is the capacity to regen-
erate tissue after injury. The in vivo prostate regeneration assay
can measure this activity (Xin et al., 2003). The PrSC-enriched
population of prostate cells can regenerate prostatic tubules in
SCID mice both subrenally in collagen, and subcutaneously,
when injected in Matrigel (Lawson et al., 2007). We tested
whether Bmi-1 inhibition alters this PrSC property.
Dissociated prostate cells from C57/Bl6 mice were infected
with scrambled or Bmi-1 shRNA lentivirus and cultured in vitro
in Matrigel for 72 hr to allow for viral integration and fluorescent
protein expression. Infected cells were sorted via FACS, gating
on RFP expression. Sorted cells were combined with UGSM
and injected subcutaneously into SCID mice (Figure 5A). After
10 weeks, grafts were harvested and analyzed for the presence
of fluorescence signal. Bmi-1 shRNA grafts contained little to no
red fluorescence signal, whereas the scrambled shRNA grafts
had several red tubules visible under the dissecting microscope
(Figure 5B, top; Table S2). Microscopic analysis of H&E sections
and fluorescence signal confirms that significantly fewer
and smaller tubules were regenerated upon Bmi-1 inhibition.
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Figure 4. Bmi-1 Is Required for b-Catenin-Mediated Self-Renewal
(A) Diagram of experimental approach.
(B) Number of spheres formed in two generations of RFP- and Cre-infected Catnb+/Lox(Ex 3) prostate cells.
(C and D) Western blot (C) and Q-PCR (D) analysis of b-catenin, b-catenin target genes, and Bmi-1 expression levels in RFP-infected (WT) and Cre-infected
(Ex3 KO) cells.
(E) Frequency of 1 and 2 spheres from RFP, Cre/scrambled, and Cre/Bmi-1 shRNA-infected Catnb+/Lox(Ex 3) cells normalized to generation 1 RFP spheres.
Data represented as mean ± SEM.
(F) Images of representative Cre/scrambled and Cre/Bmi-1 shRNA-infected spheres. Scale bars represent 200 mm.
See also Figures S1E and S5.
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Bmi-1 in Prostate Stem Cells and Cancer(Figure 5B, bottom; Figure 5C). Both grafts contained a few
noncolored tubules, which probably grew from residual nonin-
fected prostate cells. Quantification of the average number of
fluorescent tubules per viewing field shows an 85% decrease
in tubules (Figure 5C). Because both scrambled and Bmi-1
shRNA-infected cells were sorted after infection via the same
sorting gate, we can be certain that equal numbers of cells
with similar infection levels were implanted. Therefore, the
decrease in tubule-regeneration activity can be attributed only
to the loss of Bmi-1. Bmi-1 shRNA-infected tubules expressCelcytokeratin 8 and AR, but have low cytokeratin 5 and p63
expression, indicating a more differentiated state (Figure S6).
Loss of Bmi-1 Protects Prostate Cells
from FGF10-Driven Hyperplasia
Similar to human prostate cancer, Bmi-1 is overexpressed in
mouse models of prostate cancer. Heightened fibroblast growth
factor (FGF) 10 signaling in UGSM cells leads to a hyperplastic
phenotype in nearby mouse epithelium (Memarzadeh et al.,
2007). Analysis of such regenerated grafts reveals higherl Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Inc. 687
Infect with
shRNA 
Lenti
In vivo regeneration
S
c
r
 s
h
R
N
A
B
m
i-
1
 s
h
R
N
A
0
5
10
15
N
u
m
b
e
r
 
o
f
 
t
u
b
u
l
e
s
/
v
i
e
w
i
n
g
 
f
i
e
l
d
Scr shRNA
Scr shRNA
H&E
H&E
Bmi-1 shRNA
Bmi-1 shRNA
H&E
H&E
CB
A
Dissociated
cells
UGS/
prostate
C57BL/6
mouse
Sort infected 
cells
Plate in Matrigel 
for 72 hrs
Scrambled shRNA Bmi-1shRNA
Scr shRNA Bmi-1 shRNATI TI
***
Figure 5. Loss of Bmi-1 Decreases In Vivo Prostate Tubule Formation
(A) Schematic of experimental approach.
(B) Top: TI images of regenerated grafts and fluorescent images of RFP signal that represents infection. Bottom: H&E and fluorescent images of representative
grafts of scrambled and Bmi-1 shRNA-infected primary prostate cells. RFP shows integrated virus. Scale bars represent 200 mm.
(C) Average number of RFP+ tubules per viewing field, calculated from 3 viewing fields from 12 different tissue sections of scrambled and Bmi-1 shRNA-infected
grafts (9 grafts/condition from 3 experiments were analyzed), represented as mean ± SEM.
See also Figure S6 and Table S2.
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Bmi-1 in Prostate Stem Cells and CancerBmi-1 staining in the hyperplastic epithelium exposed to the
FGF10-expressing UGSM than in the normal tubules grown
with control UGSM (Figure S7A). If prostate cancer cells exploit
the normal stem cell pathways, then modulating Bmi-1 may
attenuate the initiation of cancer.
Primary prostate cells infected with scrambled or Bmi-1
shRNA were combined with FGF10-infected UGSM cells
(Figure 6A). After 8 weeks in vivo, cells infected with Bmi-1
shRNA formed smaller grafts, as shown by weight and size
(Figures 6B and 6C, top). Fluorescence images confirm that
Bmi-1 shRNA grafts contain fewer and smaller tubules, even in
the presence of heightened FGF10 signaling (Figure 6C, bottom).
Histological analysis reveals that uninfected and scrambled
shRNA-infected tubules had a mostly hyperplastic phenotype
that closely resembles high-grade mPIN lesions (Figure 6D),
similar to previously reported studies (Memarzadeh et al.,
2007). In contrast, the majority of Bmi-1 shRNA-infected tubules
contained a single or double layer of cells and retained a normal
appearance in the presence of heightened FGF10 (Figure 6D).
Infected regions from 10 histological sections from 3 representa-
tive grafts each were counted and classified as normal or
hyperplastic. Although 85% of scrambled shRNA-infected
tubules had a hyperplastic phenotype, 90% of the Bmi-1688 Cell Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier IncshRNA-infected tubules appeared normal (Figure 6E), despite
growing in an environment with high FGF10 expression.
Immunofluorescence analysis reveals that uninfected and
scrambled shRNA-infected regions have increased AR and
p63 expression along with increased Ki67 staining. The region
infected with Bmi-1 shRNA contains few p63-positive cells and
Ki67-positive cells, again resembling normal tubules in the
regeneration assay (Figure 6F). These results show that Bmi-1
expression and the self-renewal and proliferative properties it
allows are necessary for prostate epithelial cells to respond to
FGF10 signaling-induced transformation.
Loss of Bmi-1 Attenuates Oncogenic Progression
in the Pten Null Prostate Cancer Model
PTEN (phosphatase and tensin homolog deleted on chromo-
some 10) is a potent tumor suppressor gene that is frequently
mutated in prostate cancer. Cre/Lox-mediated conditional dele-
tion of Pten in the murine prostate recapitulates the disease
progression in humans (Wang et al., 2006). Bmi-1 is upregulated
in the Pten null prostate at the mRNA and protein levels (Figures
S7B and S7C). Dissociated prostate cells from PtenLoxP/LoxP
mice were infected with lentivirus containing either Cre/scram-
bled or Cre/Bmi-1 shRNA (Figure 7A). Grafts harvested after.
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Bmi-1 in Prostate Stem Cells and Cancer8 weeks reveal that cells infected with Cre/scrambled shRNA
formed large tumors (Figure 7B). The PtenLoxP/LoxP cells infected
with Cre/Bmi-1 shRNA were also transformed, but the grafts
were significantly smaller in size (Figure 7B). The Cre/scrambled
shRNA-infected grafts had a much more densely packed
appearance (Figure 7C), whereas the Cre/Bmi-1 shRNA-infected
tumors had lower cellular content (Figure 7D, top). There wereCelfewer Ki67+ proliferating cells and more TUNEL-positive
apoptotic cells in the Cre/Bmi-1 shRNA grafts compared to the
Cre/scrambled shRNA grafts (Figures 7C and 7D, bottom).
Altering a single self-renewal gene in the prostate significantly
attenuates the initiation and growth of an aggressive form of
prostate cancer by affecting proliferation and apoptosis in the
cancer cells.l Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Inc. 689
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Our finding that Bmi-1 loss induces an exhaustion of PrSCs
and a depletion of the LSC stem cell fraction as well as the
p63+ primitive cells is similar to what is seen in postnatal hema-
topoiesis, where loss of Bmi-1 significantly reduces the number
of HSCs (Park et al., 2003). Bmi-1 is also required for the self-
renewal of stem cells in the peripheral and central nervous
system, and loss of Bmi-1 results in postnatal growth retardation
and neurological defects (Molofsky et al., 2005). These results
highlight the conserved role of Bmi-1 across cells derived from
all three germ layers.
Bmi-1 has been shown to regulate leukemic stem cell self-
renewal as well (Lessard and Sauvageau, 2003). Loss of Bmi-1
in HSCs did not prevent primary leukemia formation. Only
when leukemic cells were transplanted into secondary recipi-
ents was there a difference in leukemiagenesis. In contrast,
loss of Bmi-1 completely prevented the formation of prostate
hyperplasia in the FGF10 model and significantly attenuated
the primary outgrowth of prostate cancer induced by Pten
deletion.
Bmi-1 expression patterns also vary between tissues. Bmi-1
lineage tracing experiments in pancreas show that Bmi-1+ cells690 Cell Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Incare differentiated and coexpress lineage markers and Ki67,
indicating that Bmi-1 is present in more differentiated prolifer-
ating cells. The detection of Bmi-1+ cells 1 year after pulse-chase
marking experiments indicates that Bmi-1 is also present in
a subpopulation of self-renewing pancreatic acinar cells (San-
giorgi and Capecchi, 2009). In contrast, Bmi-1 is only expressed
in the stem cells of the intestine, and the Bmi-1+ cells do not cos-
tain for differentiation markers (Sangiorgi and Capecchi, 2008).
Our cell fractionation studies reveal that Bmi-1 expression is
highest in the prostate basal/stem cell-enriched fraction. This
fraction can be further divided into Trop2hi stem and Trop2lo
basal subpopulations (Goldstein et al., 2008). Bmi-1 was highest
in the Trop2hi stem cell fraction, but was still present in the
Trop2lo basal cell population as well (data not shown), suggest-
ing that Bmi-1 is not solely expressed by the most primitive cells
of the prostate. Weissman and colleagues used a Bmi-1-GFP
mouse to show similar results in the hematopoietic system,
where Bmi-1 is highest in the HSCs, but also present in certain
progenitors (Hosen et al., 2007). Occasionally, Bmi-1 was found
in a few adluminal cells in the proximal region of the prostate.
These cells may be related to the recently characterized CARNs
cells, which represent rare luminal stem cells that have tumor-
initiating capacities (Wang et al., 2009)..
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whose deletion causes a failure to develop stratified epithelia
and epithelial appendages in mice, in addition to prostate agen-
esis (Yang et al., 1999). Signoretti et al. complemented p63/
blastocysts with p63+/+ galactosidase+ embryonic stem cells
and found that luminal cells of the prostate originated only
from p63+ donors, which suggests the defects of the p63 null
stem cells in proliferation and self-maintenance (Signoretti
et al., 2000). p63 also marks the more stem-like cells in the
prostate (Xin et al., 2007).
In our study, Bmi-1 overexpression led to an expansion of
these p63+ cells in p53/ prostate spheres. Furthermore, we
observed a breakdown in cellular organization of the spheres,
where the p63+ cells normally confined to the outer rim of
spheres expanded in toward the middle (Figure 3C). Such
adluminal expansion of p63+ cells has also been observed in
several models of murine prostate cancer (Memarzadeh et al.,
2007; Wang et al., 2006). The FGF10 model of prostate hyper-
plasia is an overgrowth and excessive branching of the basal/
stem cell population of prostate cells, characterized by a
concomitant expansion of p63+ cells. The most primitive pros-
tate cells, which are also p63+, are the most susceptible to
such transformation (Lawson et al., 2010). Our data suggest
that inhibition of Bmi-1 was able to prevent this form of hyper-
plasia because loss of Bmi-1 caused a depletion of this p63+
LSC population. This finding may have important implications
in other epithelial cancers, because many are thought to initiate
from stem cells.
The evolutionarily conserved pathways Wnt, Sonic Hh (Shh),
Notch, and the Polycomb Group protein Bmi-1 are consistently
found involved in stem cell self-renewal from Drosophila to
humans. Interactions between these pathways have been well
documented. Both Wnt and Shh signaling are important for
neural tube development, neural stem cell proliferation, and
self-renewal (Michaelidis and Lie, 2008; Patten and Placzek,
2000; Wechsler-Reya and Scott, 1999). Wnt pathway inhibitors
can regulate threshold responses to Shh target genes, demon-
strating the existence of mechanisms that integrate graded
Shh and Wnt signaling to determine cell fate decisions in the
neural tube (Lei et al., 2006). Wnt-1, Hh, and Bmi-1 have all
been shown in mammary stem cells to influence self-renewal
and regenerative capacities (Asselin-Labat et al., 2008). Increase
in Hh signaling directly upregulates Bmi-1 expression, and it is
the level of Bmi-1 that controls mammary stem cell self-renewal
(Liu et al., 2006). Attempts were made to test the importance of
Bmi-1 for Hh-driven self-renewal in the prostate. In contrast
to mammary stem cells, Hh overactivation through Lentiviral
overexpression of Gli-1 and the addition of rShh to PrSCs did
not result in a sustained increase in sphere forming and self-
renewal activity in our assay (data not shown). Therefore, the
effects of Bmi-1 inhibition were not tested in these conditions.
Interestingly, it also took an extra generation to see significant
differences in sphere forming activity in response to Bmi-1 over-
expression, whereas mammary sphere formation increased in
generation 1. Both of these findings could be due to the fact
that prostate cells are more sensitive to oncogene-induced
senescence.
b-catenin stabilization did increase self-renewal in the pros-
tate, and Bmi-1 loss reversed this gain of sphere forming activity.CelIn contrast to the interactions between Hh and Bmi-1 in the
mammary, b-catenin signaling does not appear to activate
Bmi-1 signaling directly and Bmi-1 is probably not downstream
of b-catenin. These findings suggest that Bmi-1 and b-catenin
are acting in parallel to control self-renewal, and Bmi-1 is neces-
sary for b-catenin to affect this process. Bmi-1 expression and
resulting chromosomal modifications may set the cell to
a specific state that allows for self-renewal and proliferation.
Even if several developmental pathways are active in certain
epithelial stem cells, controlling Bmi-1 may be enough to modu-
late self-renewal. With the close relationship between stem cell
self-renewal and cancer progression, this finding has important
implications for controlling cancer growth as well.
EXPERIMENTAL PROCEDURES
Mouse Strains
Most animal experiments were conducted with C57BL/6 and CB17Scid/Scid
mouse strains, which were originally purchased from The Jackson Laboratory
(Bar Harbor, ME). PtenloxP/loxP and Catnb+/Lox(ex3) mice were provided by H.W.
Mice were housed and bred in our animal facilities under the regulation of the
Division of Laboratory Animal Medicine at the University of California, Los
Angeles.
Prostate Cell Preparation, Cell Sorting, and Primary Cell Culture
The preparation of prostate epithelial cell suspensions frommale mice and cell
sorting parameters for stem/basal and luminal cell populations were described
previously (Lawson et al., 2010; Lukacs et al., 2010). Prostate sphere assay
used for in vitro analysis and passaging has been described (Xin et al.,
2007). In brief, 5,000 to 50,000 prostate cells were resuspended in 100 ml of
a 50:50 mixture of Matrigel (BD) and PrEGM (Lonza) and plated around the
rim of a well of a 12-well tissue culture plate. Matrigel mix was allowed to
solidify at 37C, and 800 ml of PrEGM was added. Media was changed every
3 days. To recover the spheres, wells were treated with 1 mg/ml Dispase
solution (GIBCO). Spheres were digested with Trypsin 0.05% EDTA, triturated
through a 27 gauge needle, and filtered through a 40 mm filter.
Vector Production and Viral Packaging
Third-generation lentiviral vectors FUCGW and FUCRW, derived from FUGW
(Lois et al., 2002; Xin et al., 2006), were used for the construction of the Bmi-1
overexpression and all shRNA vectors. Murine Bmi-1 was PCR amplified from
a pGEM vector containing the open reading frame of Bmi-1 (a generous gift
from Dr. Sean Morrison) and XbaI sites were added for cloning. An shRNA
against Bmi-1 was designed to target the mouse Bmi-1 ORF (TAAAGGATTAC
TACACGCTAATG). A scrambled shRNA was designed by mutating three of
the antisense nucleotides in the Bmi-1 shRNA sequence. shRNAs were cloned
downstream of the H1 promoter. The shRNA-resistant clone of murine Bmi-1
was made by introducing three silent mutations into the shRNA target region
of Bmi-1. Specific cloning steps of all created vectors are provided in
Supplemental Information.
Immunohistochemistry
Frozen sections were prepared from 8-week-old prostates and fixed in cold
acetone. Prostate spheres and regenerated grafts were fixed in 10% buffered
formalin and placed in 70% ethanol. Sections (4 mm) were stained with hema-
toxylin and eosin (H&E) or with specified antibodies. Please see Supplemental
Information for specific antibody information. Coverslips were mounted and
sections were counterstained with DAPI (Vector), and sections were visualized
with fluorescence microscopy.
RNA Extraction, q-RT-PCR, and Western Blot Analysis
Sorted cells and dissociated sphere cells were lysed in Buffer RLT and RNA
was extracted with RNeasy Micro Kit (QIAGEN). RNA was reverse transcribed
with SuperScriptIII First Strand kit (Invitrogen). Q-PCR analysis was set up with
iQ SYBR Green Supermix kit (BioRad). Primers used for Q-PCR can be found
in Supplemental Information.l Stem Cell 7, 682–693, December 3, 2010 ª2010 Elsevier Inc. 691
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Information). Equal amounts of protein lysates (5–20 mg/lane) were separated
by SDS-PAGE (Invitrogen), transferred onto nitrocellulose membranes, which
were blocked in 5% milk for 1 hr at RT, and blotted with antibody overnight at
4C (antibody information in Supplemental Information). Peroxidase-conju-
gated secondary antibodies (BioRad) were used at 1:10,000 for 1 hr at RT.
ECL (Millipore) was the chemiluminescent substrate and blots were developed
with Kodak Film.
Subcutaneous and Subrenal Prostate Regeneration Assays
The details of the regeneration process have been explained previously
(Lukacs et al., 2010). Housing, maintenance, and all surgical procedures
were undertaken in compliance with the regulations of the Division of Labora-
tory Animal Medicine of the University of California, Los Angeles. In brief,
C57Bl6-dissociated prostate cells were infected with scrambled or Bmi-1
shRNA, cultured in Matrigel for 72 hr, and sorted by FACS (for the RFP+ pop-
ulation). Cells were combined with UGSM, mixed with Matrigel, and injected
subcutaneously into SCID mice. For the FGF10 experiments, scrambled or
Bmi-1 shRNA-infected epithelial cells were combined with FGF10-infected
UGSM. For the Pten experiments, PtenLoxP/LoxP prostate cells were infected
with Cre/Scrambled or Cre/Bmi-1 shRNA lentivirus and combined with wild-
type UGSM. Cells were mixed with collagen and implanted under the renal
capsule of male SCID mice.
Statistical Analysis
All experiments were performed with at least three different primary cultures or
animals in independent experiments. Significance was evaluated by Student’s
t test. Data are presented as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
doi:10.1016/j.stem.2010.11.013.
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